Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.

doi:10.1128/JVI.70.3.1818-1827.1996

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.

Journal of virology - 1 Mar 1996

Gubareva L V, Bethell R, Hart G J, Murti K G, Penn C R, Webster R G

Abstract excerpt

The development of viral resistance to the neuraminidase (NA) inhibitor, 4-guanidino-Neu5Ac2en, of influenza viruses was studied by serial passage of A/Turkey/Minnesota/833/80 (H4N2) in Madin-Darby canine kidney cells in the presence of increasing concentrations of inhibitor. Resistant mutants selected after eight passages, had a 10,000-fold reduction in sensitivity to the inhibitor in plaque assays, but their...

Topics

Animals
Antiviral Agents
Base Sequence
Cell Line
DNA, Viral
Dogs
Drug Resistance, Microbial
Enzyme Inhibitors
Guanidines
Influenza A virus
Molecular Sequence Data

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Mutation

Neuraminidase

Pyrans

Sialic Acids

Turkeys

Zanamivir

Source

Open in PubMed Open full text

Identifiers

PMID: 8627706
DOI: 10.1128/JVI.70.3.1818-1827.1996
PMCID: PMC190009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.PMID 8627706Read ↗

Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.Semantic proximity Read ↗

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.Semantic proximity Read ↗

Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture.Semantic proximity Read ↗

Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.Semantic proximity Read ↗

Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140.Semantic proximity Read ↗

Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors.Semantic proximity Read ↗

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.Semantic proximity Read ↗

Influenza A viruses serially passaged in different MDCK cell lines exhibit limited sequence variation across their genomes, with the exception of the hemagglutinin geneSemantic proximity Read ↗

Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.Semantic proximity Read ↗

In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses.Semantic proximity Read ↗

Influenza A (H1N1) virus resistance to cyanovirin-N arises naturally during adaptation to mice and by passage in cell culture in the presence of the inhibitor.Semantic proximity Read ↗

A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.